Immunocore
IMCR
116 hedge funds and large institutions have $1.4B invested in Immunocore in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 14 closing their positions.
88% more call options, than puts
Call options by funds: $6.54M | Put options by funds: $3.48M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
30% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 33
3.68% more ownership
Funds ownership: 90.77% → 94.45% (+3.7%)
7% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 14
5% more capital invested
Capital invested by funds: $1.34B → $1.4B (+$63.5M)
1% more funds holding
Funds holding: 115 → 116 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$26.8M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$24.2M |
| 3 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$14.1M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$10.8M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$14.6M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.99M |
| 3 |
Millennium Management
New York
|
-$8.64M |
| 4 |
AC
Armistice Capital
New York
|
-$6.66M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$4.58M |
IMCR Hedge Fund Activity: Q1 2025 in Review
116 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Immunocore (IMCR) for Q1 2025, worth a combined $1.4B — up 4.7% from $1.34B a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new IMCR positions and 14 closed out — a net gain of 1 holder — while 43 added to existing stakes and 33 trimmed.
The largest buyer was Deep Track Capital, adding an estimated $26.8M. The largest seller was Wellington Management Group, cutting an estimated $14.6M.
- 116 institutional investors held Immunocore (IMCR) as of Q1 2025, up from 115 in Q4 2024.
- Funds reported $1.4B of Immunocore stock for Q1 2025, up 4.7% quarter-over-quarter.
- 15 funds opened new Immunocore positions in Q1 2025 and 14 closed out, a net change of +1 holder.
- The largest Immunocore buyer in Q1 2025 was Deep Track Capital, an estimated $26.8M added.
- The largest Immunocore seller in Q1 2025 was Wellington Management Group, an estimated $14.6M sold.
Based on aggregated 13F filings for Q1 2025.